AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 293: R2194-R2201, 2007. First published October 17, 2007; doi:10.1152/ajpregu.00385.2007
0363-6119/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/6/R2194    most recent
00385.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Santollo, J.
Right arrow Articles by Eckel, L. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santollo, J.
Right arrow Articles by Eckel, L. A.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Acute activation of ER{alpha} decreases food intake, meal size, and body weight in ovariectomized rats

Jessica Santollo, Mathew D. Wiley, and Lisa A. Eckel

Program in Neuroscience and Department of Psychology, Florida State University, Tallahassee Florida

Estradiol exerts many of its actions by coupling with two nuclear estrogen receptor (ER) proteins, ER{alpha}, and ERβ.While the acute, anorexigenic effect of estradiol appears to involve such a mechanism, the relative contributions of ER{alpha} and ERβ are equivocal. To address this problem, food intake was monitored in ovariectomized (OVX) rats following acute administration of a selective ER{alpha} agonist (4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol, PPT; dose range = 0–200 µg), a selective ERβ agonist (2,3-bis(4-hydroxyphenyl)-propionitrile, DPN; dose range = 0–600 µg), and a physiological (4 µg) dose of estradiol benzoate (EB). While PPT-treated rats displayed dose-dependent decreases in daily food intake and body weight, neither of these measures was influenced by any dose of DPN. In addition, DPN failed to modulate the anorexigenic effect of PPT when the two ER agonists were coadministered. Meal pattern analysis revealed that the anorexigenic effect of 75 µg PPT (a dose of PPT that produced a similar decrease in daily food intake as 4 µg EB) was mediated by a decrease in meal size, not meal number. Thus, PPT, like EB and endogenous estradiol, decreases food intake by selectively affecting the controls of meal size. The finding that acute administration of 75 µg PPT failed to induce a conditioned taste aversion suggests that the anorexigenic effect of this dose of PPT is not secondary to malaise. Taken together, our findings demonstrate that selective activation of ER{alpha} decreases food intake, body weight, and meal size in the ovariectomized rat.

4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol; 2,3-bis(4-hydroxyphenyl)-propionitrile; food intake; estradiol



Address for reprint requests and other correspondence: L. A. Eckel, Associate Professor, Dept. of Psychology, Florida State Univ., Tallahassee, FL 32306-1270 (e-mail: eckel{at}psy.fsu.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.